FYERS
Home
/
Stocks
/
Results
/
Eiko Lifesciences Results

Eiko Lifesciences Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--153%262%
--121%164%
--9%-5%-5%
-24%-24%-33%8%

Peer Comparison

Symbol
SOLARINDS-A
PIDILITIND-A
SRF-A
FLUOROCHEM-A
NAVINFLUOR-A
GODREJIND-A
DEEPAKNTR-A
AETHER-A
AARTIIND-A
ATUL-A
EIKO-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
19,938.5₹181749 Cr91.2772.11250.42₹1678 Cr
1,503.95₹153351 Cr57.898.5729.89₹2449 Cr
2,495.75₹73936 Cr34.225.6102.33₹1835 Cr
4,498.45₹50872 Cr82.7220.0990.49₹577 Cr
8,257.85₹43404 Cr54.9647.43184.25₹664 Cr
1,016.65₹33843 Cr28.798.4450.37₹1241 Cr
1,616.9₹22444 Cr28.6525.2974.81₹551 Cr
1,619.85₹22320 Cr94.94.7323.27₹219 Cr
500.65₹18056 Cr344.2827.98₹419 Cr
6,147.55₹17574 Cr22.0983.32378.24₹678 Cr
49.18₹72 Cr14.071.054.17₹5 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹11 Cr₹7 Cr₹8 Cr₹11 Cr₹84 L₹56 L₹62 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹41 L₹13 L₹32 L₹26 L₹27 L₹23 L₹9 L₹13 L₹26 L₹1 L₹5 L-₹4 L₹1 L₹5 L₹3 L₹3 L₹0₹2 L₹1 L
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹12 Cr₹8 Cr₹8 Cr₹11 Cr₹85 L₹61 L₹58 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹15 Cr₹16 Cr₹10 Cr₹10 Cr₹9 Cr₹10 Cr₹7 Cr₹8 Cr₹11 Cr₹93 L₹46 L₹2 Cr₹5 Cr₹6 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹73 L₹55 L₹66 L-₹4 L₹18 L-₹96 L-₹1 Cr-₹2 Cr-₹39 L-₹33 L-₹12 L-₹15 L-₹9 L
₹13 L₹12 L₹7 L₹10 L₹5 L₹7 L₹3 L₹4 L₹3 L₹10 L₹70,000₹3 L₹8 L₹6 L₹7 L₹15 L₹2 L₹5 L₹4 L
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹54 L₹35 L₹46 L-₹18 L₹14 L-₹1 Cr-₹1 Cr-₹2 Cr-₹50 L-₹60 L-₹18 L-₹24 L-₹18 L
₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹40 L₹26 L₹35 L-₹13 L₹10 L-₹74 L-₹1 Cr-₹1 Cr-₹37 L-₹45 L-₹14 L-₹17 L-₹13 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2020Mar 2019Mar 2018
————
₹14 Cr₹4 Cr₹4 Cr₹4 Cr
₹43 Cr-₹87 L₹1 Cr₹2 Cr
₹43 Cr-₹87 L₹1 Cr₹2 Cr
₹57 Cr₹3 Cr₹5 Cr₹6 Cr
₹22 L-₹2 Cr-₹12 L₹22 L
₹2 Cr₹2 Cr₹42 L₹48 L
₹82 L-₹2 Cr-₹27 L₹3 L
₹3 Cr-₹2 L₹15 L₹51 L
————
₹3 Cr₹4 Cr₹1 Cr₹2 Cr
₹2 Cr₹5 Cr₹2 Cr₹1 Cr
₹76 L₹0₹94 L₹1 Cr
₹40 L₹4 L₹5 L₹6 L
₹6 Cr₹9 Cr₹4 Cr₹5 Cr
₹66 Cr₹10 Cr₹9 Cr₹11 Cr
₹3 Cr₹2 Cr₹1 Cr₹2 Cr
————
₹26 Cr₹3 Cr₹2 Cr₹2 Cr
₹3 Cr₹93 L₹74 L₹58 L
₹23 Cr₹2 Cr₹2 Cr₹2 Cr
₹7 Cr₹10 L₹2 Cr₹3 Cr
₹7 Cr₹10 L₹2 Cr₹3 Cr
₹3 Cr₹2 Cr₹5 L₹4 L
₹0₹1 Cr₹1 Cr₹8 L
₹33 Cr₹5 Cr₹5 Cr₹5 Cr
————
₹6 Cr₹3 Cr₹2 Cr₹3 Cr
₹11 Cr₹1 Cr₹86 L₹1 Cr
₹12 Cr₹2 L₹11 L₹80 L
₹23,000₹14 L₹31 L₹4 L
₹5 Cr₹47 L₹58 L₹57 L
₹33 Cr₹5 Cr₹4 Cr₹6 Cr
₹27 Cr-₹4 Cr₹9 L₹1 Cr
₹66 Cr₹10 Cr₹9 Cr₹11 Cr
₹41₹8₹13₹15
₹41₹8₹13₹15

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2020Mar 2019Mar 2018
₹3 Cr-₹5 Cr-₹100 L₹0
-₹15 L₹36 L₹34 L₹0
₹32 L₹4 Cr₹84 L₹0
₹3 Cr-₹30 L₹19 L₹0
₹3 Cr-₹33 L₹16 L₹0
-₹11 Cr-₹71 L-₹30 L₹0
₹7 Cr₹95 L-₹55 L₹0
-₹2 Cr-₹9 L-₹69 L₹0
₹13 Cr₹11 L₹80 L₹0
₹12 Cr₹2 L₹11 L₹0

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)49.09
Volume (₹)3,159.00
High (₹)49.09
Upper Circuit58.62
Low (₹)47.36
Lower Circuit39.08
Prev Close48.85
52W High (₹)64.44
Price48.89
52W Low (₹)43.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)71.57 Cr
Div. Yield (%)0.00
PE Ratio14.06
Debt to Equity0.05
Price to Book1.27
Book Value41.26
EPS (TTM)3.47
Face Value10.00
ROE (%)7.76

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDS-ANSE
PIDILITIND-ANSE
SRF-ANSE
FLUOROCHEM-ANSE
NAVINFLUOR-ANSE
GODREJIND-ANSE
AETHER-ANSE
DEEPAKNTR-ANSE
AARTIIND-ANSE
ATUL-ANSE
EIKO-XNSE
LTP
1W Low
1W High
Market cap (₹)
20085+190.55 (0.96%)
19912.05
20373.65
1,81,930Cr
1505.6+25.45 (1.72%)
1462.75
1506.15
1,52,271Cr
2494.25-19.35 (-0.77%)
2454.50
2535
73,810Cr
4624.2+148.75 (3.32%)
4488.50
4678
49,998Cr
8456.35+107.4 (1.29%)
8333
8636.55
43,440Cr
1006.65+20.6 (2.09%)
978.75
1012.70
33,630Cr
1683.55-64.1 (-3.67%)
1659.80
1806.60
22,785Cr
1648+27.3 (1.68%)
1599.90
1660
22,109Cr
494.85+34.6 (7.52%)
460.95
499.75
17,680Cr
5965+88.15 (1.50%)
5929.65
6069
17,655Cr
48.89+2.24 (4.80%)
46.85
49.09
72Cr

Eiko Lifesciences Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹2.35Cr; with other income of ₹41.1Lakh, profit before interest and tax came to ₹2.1Cr. Interest expense was ₹13Lakh; PBT before exceptional items stood at ₹1.97Cr. Cost mix (full year): raw materials ₹35.04Cr; employee cost ₹34.65Lakh; depreciation ₹25.4Lakh; other expenses ₹14.81Cr. Basis: consolidated annual results.

Eiko Lifesciences Ltd Quaterly Results Key Takeaways

Eiko Lifesciences Ltd reported ₹16.75Cr total income from operations in Jun 2026, softer than ₹18.34Cr in Mar 2026 but higher than ₹10.71Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹2.35Cr; with other income of ₹41.1Lakh, profit before interest and tax came to ₹2.1Cr. Interest expense was ₹13Lakh, taking profit before tax to ₹1.97Cr. After tax of ₹49.1Lakh, profit after tax stood at ₹1.47Cr (vs ₹1.53Cr in Mar 2026 and ₹1.11Cr in Jun 2025).